- Home
- RDHL
as 10-27-2025 9:38am EST
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
| Founded: | 2009 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 3.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 4.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.06 - $8.75 | Next Earning Date: | 09-05-2025 |
| Revenue: | $9,550,000 | Revenue Growth: | 157.62% |
| Revenue Growth (this year): | 381.91% | Revenue Growth (next year): | N/A |
Latest Redhill Biopharma Ltd. News
RDHL Breaking Stock News: Dive into RDHL Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
RedHill Biopharma Receives Nasdaq Staff Determination Notification
MT Newswires
7 days ago
Cumberland to Invest in RedHill Biopharma's Talicia Business
PR Newswire
8 days ago
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
PR Newswire
8 days ago
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
PR Newswire
22 days ago
RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®
PR Newswire
2 months ago
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
MT Newswires
3 months ago
Sector Update: Health Care Stocks Softer Monday Afternoon
MT Newswires
3 months ago
RedHill Biopharma Receives Positive Feedback From FDA on Crohn's Disease Treatment; Shares Rise
Compare RDHL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RDHL Redhill Biopharma Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.